DenisIBeckerMD

Endocrinology • Raleigh, NC

Diabetes, Osteoporosis & Bone Metabolism Medicine, Thyroid

Associate Consulting Professor in the Department of Medicine, Duke University School of Medicine

Join to view full profile

Dr. Becker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Becker's full profile

Already have an account?

Office
2709 Blue Ridge Rd
Suite 320
Raleigh, NC 27607
Phone+1 919-876-7692

Fax+1 919-954-3365

Education & Training

University of North Carolina HospitalsFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1977
University of North Carolina at Chapel Hill School of MedicinePost-Doctoral Fellowship, 1975 - 1977
Cleveland Clinic FoundationResidency, Internal Medicine, 1973 - 1975
Cleveland Clinic FoundationInternship, Internal Medicine, 1972 - 1973
University of Kentucky College of MedicineClass of 1972
Rutgers UniversityBA, 1968

Certifications & Licensure

NC State Medical License 1974 - 2025
OH State Medical License 1974 - 1974
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

1 citations
Pediatric use of insulin pumps: longer infusion site lifetime with NovoLog.
Denis I. Becker
Diabetes Care. 2002-09-01

Journal Articles

Marrow Cell Chromosome Aberrations Following I.V. DMBA Dose Response.
Denis I. Becker, The Journal of the Kentucky Medical Association, 68: 291-2
o,p’ DDD Therapy in Adrenocortical Carcinoma.
Denis I. Becker and O. Peter Schumacher, Ann. Of Inter. Med., 82: 677-9
In Vitro Secretion of Immunoreactive Rat Calcitonin.
Cary Cooper, Warren Ramp, Denis Becker, David Ontjes, Endocrinology, 101: 304-311
Thyroid Function Testing: An Introduction to the Thyrotropin-Releasing Hormone (TRH) Stimulation Test.
Denis I. Becker, M.D, North Carolina Medical Journal, 39: 486-488
Circulating Calcitonin in Lactating Women.
D. I. Becker, S. U. Toverud, D.A. Ontjes, and C. W. Cooper, J. Endocrinol. Invest., 2: 159
Which Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?
Mark L. Hartman, Brenda J. Crowe, Beverly M. K. Builler, Ken K. Y. Ho, David R. Clemmons and John J. Chipman, The Journal of Clinical Endocrinology and Metabolism 87(2): 477-485
Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin.
Wartofsky L, rhTSH-Stimulated Thyroglobulin Study Group, Thyroid 12(7): 583-590
Implementation of screening and staging of relatives.
Denis I. Becker, Study Group Member, Transplantation Proceedings. 27:3377
Islet Cell Antibody-Positive Relatives With Human Leukocyte antigen DQA1 0102, DQB1 0602; Identification by the Diabetes Prevention Trial – Type 1.
Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP, The Diabetes Prevention Trial- Type 1 Study Group, Journal of Clinical Endocrinology and Metabolism, 85: 1255-1260
Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria.
Greenbaum CJ, Cuthbertson DD, Krischer JP, and the The Diabetes Prevention Trial of Type 1 Diabetes Study Group, Diabetes 50:470-476
First-phase Insulin Release During the Intravenous Glucose Tolerance Test As A Risk Factor For Type 1 Diabetes.
Chase HP, Cuthbertson DD, Dolan LM, Kaufman F, Krischer JP, Schatz DA, White NH, Wilson DM, Wolfsdorf J, The Diabetes Prevention Trial – Type 1 Study Group, Journal of Pediatrics 138:244-249
Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies Among Cytoplasmic ICA+ Relatives Is Associated “With Eligibility for the Diabetes Prevention Trial ...
Yu L, Cuthbertyson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP, DPT-1 Participating Investigators, Diabetes 50: 1735-1740
Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus.
Diabetes Prevention Trial – Type 1 Diabetes Study Group (Becker DI – Study Group Member), New England Journal of Medicine 346:1685-1691
Join now to see all

Abstracts/Posters

In Vitro Secretion of Immunoreactive Rat Thyrocalcitonin (TCT).
Cary W. Cooper, Warren K. Ramp, Denis I. Becker, and David A, Federation Proceedings. 35: 301 (Abstract #531)
Hormonal Control of Calcium Metabolism in Lactation.
S. U. Toverud, Denis I. Becker, A. Boass, C. W. Cooper, P. F. Hirsch, D. A. Onjtes, T. C. Peng, and W. K. Ramp, Proceedings of the Sixth Parathyroid Conference, Vancouver, Canada

Lectures

Pediatric Use of Insulin Pump: Longer Infusion Site Lifetime With Novolog.
15th Annual Conference of the Pediatric Endocrinology Nursing Society, Chicago, Illinois
Specialty Referral Guidelines For People With Diabetes.
American Healthways Consensus Conferences
Inpatient Management Guidelines For People With Diabetes.
American Healthways Consensus Conferences
Standards For Disease Management Programs.
American Healthways Consensus Conferences
Specialty Referral Guidelines For Cardiovascular Evaluation andManagement.
American Healthways Consensus Conferences
Join now to see all

Other

The Management of Low Testosterone, Current Approaches, New Possibilities.
GuayAT, Khera M, Becker DI, Horowitz B, Mika PJ, Winters SJ, Supplement to Review of Endocrinology
http://reviewofendo.com/articles/0208/0208_supp.pdf